168 related articles for article (PubMed ID: 148902)
21. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
[TBL] [Abstract][Full Text] [Related]
22. Effect of intrauterine contraceptive device on uterine haemostasis: a morphological study.
Aparicio SR; Bradbury K; Bird CC; Foley ME; Jenkins DM; Clayton JK; Scott JS; Rajah SM; McNicol GP
Br J Obstet Gynaecol; 1979 Apr; 86(4):314-24. PubMed ID: 435419
[TBL] [Abstract][Full Text] [Related]
23. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
24. Lochia and menstrual patterns in women with postpartum IUCD insertions.
Hingorani V; Bai U; Kakkar AN
Am J Obstet Gynecol; 1970 Nov; 108(6):989-90. PubMed ID: 5496057
[TBL] [Abstract][Full Text] [Related]
25. Aminocaproic acid and menstrual loss in women using intrauterine devices.
Kasonde JM; Bonnar J
Br Med J; 1975 Oct; 4(5987):17-9. PubMed ID: 1174902
[TBL] [Abstract][Full Text] [Related]
26. [Changes in menstrual bleeding caused by the use of the IUD].
Pedrón Nuevo N
Arch Invest Med (Mex); 1988; 19(3):245-52. PubMed ID: 3242436
[No Abstract] [Full Text] [Related]
27. Intrauterine medication with epsilon aminocaproic acid. Effect on Rhesus monkeys wearing intrauterine devices.
Shaw ST; Moyer DL; Aaronson DE; Underwood J; Forino RV
Contraception; 1975 Apr; 11(4):395-407. PubMed ID: 1122754
[TBL] [Abstract][Full Text] [Related]
28. Increased fibrinolytic activity in the endometrium of patients using copper-IUD.
Larsson B; Liedholm P; Sjöberg NO; Astedt B
Contraception; 1974 May; 9(5):531-7. PubMed ID: 4448084
[TBL] [Abstract][Full Text] [Related]
29. Ibuprofen prevents IUCD-induced increases in menstrual blood loss.
Mäkäräinen L; Ylikorkala O
Br J Obstet Gynaecol; 1986 Mar; 93(3):285-8. PubMed ID: 3516203
[TBL] [Abstract][Full Text] [Related]
30. Endometrial histology and clinical symptoms following prolonged retention of uterine contraceptive devices.
Rozin S; Sacks MI; Shenker JG
Am J Obstet Gynecol; 1967 Jan; 97(2):197-202. PubMed ID: 6017026
[No Abstract] [Full Text] [Related]
31. Clinical application of inhibitors of fibrinolysis.
Verstraete M
Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
[TBL] [Abstract][Full Text] [Related]
32. Browplasminin, a condensed tannin with anti-plasmin activity isolated from an aqueous extract of Brownea grandiceps Jacq. flowers.
Pereira B; Brazón J; Rincón M; Vonasek E
J Ethnopharmacol; 2017 Feb; 198():282-290. PubMed ID: 28089737
[TBL] [Abstract][Full Text] [Related]
33. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
34. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
[TBL] [Abstract][Full Text] [Related]
36. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
37. Increased endometrial fibrinolytic activity as a cause of menometrorrhagia in women using IUD's.
Surico N; Tavassoli K; Porcelli A; Ferraris G
Panminerva Med; 1988; 30(3):184-7. PubMed ID: 3211578
[No Abstract] [Full Text] [Related]
38. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
39. On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin.
Edlund M; Blombäck M; He S
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):593-8. PubMed ID: 12960614
[TBL] [Abstract][Full Text] [Related]
40. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
Aoki N; Moroi M; Tachiya K
Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
